Arturo Molina MD - 15 Nov 2022 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role: Chief Medical Officer
Signature: /s/ Asif Ali, Attorney-in-Fact for Arturo Molina, MD
Issuer symbol: PTGX
Transactions as of: 15 Nov 2022
Net transactions value: $0
Form type: 4
Filing time: 17 Nov 2022, 17:22:05 UTC
Previous filing: 17 Nov 2022
Next filing: 18 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTGX	Common Stock	Award	$0	+21,250		$0.000000	21,250	15 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTGX	Stock Option (right to buy)	Award	$0	+127,500		$0.000000	127,500	15 Nov 2022	Common Stock	127,500	$8.04	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents grant of restricted stock units payable solely in shares of the Issuer's common stock that will vest in four annual installments on November 15, 2023, 2024, 2025 and 2026, subject to the Reporting Person's continued service to the Issuer.
F2	The stock option represents a right to purchase a total of 127,500 shares of the Issuer's common stock, one quarter of which will vest on November 7, 2023, with the remaining three quarters vesting in equal monthly installments through November 7, 2026, subject to the Reporting Person's continued service to the Issuer.